Want to join the conversation?
In 2Q16, $MON's net sales fell 13% versus 2Q15. In 1H16, net sales dropped 16% versus 1H15. Net income attributable to Monsanto Company was $2.41 per share in 2Q16 compared to $2.92 per share in 2Q15. Net income attributable to Monsanto Company was $1.80 per share in 1H16 compared to $3.41 per share in 1H15.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.